Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Edith Mitchell
Dermatologic Toxicity Occurring During Anti-Egfr Monoclonal Inhibitor Therapy in Patients With Metastatic Colorectal Cancer: A Systematic Review
Clinical Colorectal Cancer
Oncology
Gastroenterology
Does Diabetes Mellitus Influence Pathologic Complete Response and Tumor Downstaging After Neoadjuvant Chemoradiation for Esophageal and Gastroesophageal Cancer? A Two-Institution Report
Journal of Surgical Oncology
Medicine
Surgery
Oncology
Related publications
HER2 Gene Copy Number Status May Influence Clinical Efficacy to Anti-Egfr Monoclonal Antibodies in Metastatic Colorectal Cancer Patients
British Journal of Cancer
Cancer Research
Oncology
Impact of STAT3 Phosphorylation on the Clinical Effectiveness of Anti-EGFR–Based Therapy in Patients With Metastatic Colorectal Cancer
Clinical Colorectal Cancer
Oncology
Gastroenterology
Anti-Egfr Monoclonal Antibodies in Advanced Biliary Tract Cancer: A Systematic Review and Meta-Analysis
In Vivo
Biochemistry
Medicine
Genetics
Pharmacology
Molecular Biology
Should Anti-Egfr mAbs Be Discontinued for Conversion Surgery in Untreated Right-Sided Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis
World Journal of Surgical Oncology
Surgery
Oncology
Molecular Determinants of Anti-Egfr Sensitivity and Resistance in Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
EGFR Inhibitor as Second-Line Therapy in a Patient With Mutant RAS Metastatic Colorectal Cancer: Circulating Tumor DNA to Personalize Treatment
JCO Precision Oncology
Cancer Research
Oncology
Efficacy of Sym004 in Patients With Metastatic Colorectal Cancer With Acquired Resistance to Anti-Egfr Therapy and Molecularly Selected by Circulating Tumor DNA Analyses
JAMA Oncology
Cancer Research
Oncology
Comment on ‘Clinical Significance of BRAF Non-V600e Mutations on the Therapeutic Effects of Anti-Egfr Monoclonal Antibody Treatment in Patients With Pretreated Metastatic Colorectal Cancer: The Biomarker Research for Anti-Egfr Monoclonal Antibodies by Comprehensive Cancer Genomics (BREAC) Study’
British Journal of Cancer
Cancer Research
Oncology
A Systematic Review of Treatment Guidelines for Metastatic Colorectal Cancer
Colorectal Disease
Gastroenterology
